These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31592257)

  • 1. Comparison of drug-eluting and bare metal stents for extracranial vertebral artery stenting.
    Maciejewski DR; Pieniazek P; Tekieli L; Paluszek P; Przewlocki T; Tomaszewski T; Machnik R; Trystula M; Legutko J; Kablak-Ziembicka A
    Postepy Kardiol Interwencyjnej; 2019; 15(3):328-337. PubMed ID: 31592257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and comparison of drug eluting stent to bare metal stent for restenosis rates following vertebral artery ostium stenting: A single-center real-world study.
    Li L; Wang X; Yang B; Wang Y; Gao P; Chen Y; Zhu F; Ma Y; Chi H; Zhang X; Bai X; Feng Y; Dmytriw AA; Hong T; Hua Y; Jiao L; Ling F
    Interv Neuroradiol; 2020 Oct; 26(5):629-636. PubMed ID: 32799746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-Coated Balloon Angioplasty Versus Drug-Eluting Stent Implantation in Patients With Coronary Stent Restenosis.
    Giacoppo D; Alfonso F; Xu B; Claessen BEPM; Adriaenssens T; Jensen C; Pérez-Vizcayno MJ; Kang DY; Degenhardt R; Pleva L; Baan J; Cuesta J; Park DW; Kukla P; Jiménez-Quevedo P; Unverdorben M; Gao R; Naber CK; Park SJ; Henriques JPS; Kastrati A; Byrne RA
    J Am Coll Cardiol; 2020 Jun; 75(21):2664-2678. PubMed ID: 32466881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome differences with the use of drug-eluting stents for the treatment of in-stent restenosis of bare-metal stents versus drug-eluting stents.
    Steinberg DH; Gaglia MA; Pinto Slottow TL; Roy P; Bonello L; De Labriolle A; Lemesle G; Torguson R; Kineshige K; Xue Z; Suddath WO; Kent KM; Satler LF; Pichard AD; Lindsay J; Waksman R
    Am J Cardiol; 2009 Feb; 103(4):491-5. PubMed ID: 19195508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a Drug-Eluting Stent vs. Bare Metal Stent for the Treatment of Symptomatic Intracranial and Vertebral Artery Stenosis.
    Si JH; Ma N; Gao F; Mo DP; Luo G; Miao ZR
    Front Neurol; 2022; 13():854226. PubMed ID: 35911924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of drug-eluting balloon in patients with bare-metal or drug-eluting stent restenosis.
    Berta B; Jambrik Z; Kohar K; Szabo G; Ruzsa Z; Molnar L; Barczi G; Geller L; Becker D; Merkely B
    Hellenic J Cardiol; 2014; 55(5):369-77. PubMed ID: 25243435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting vs. bare metal stents for symptomatic vertebral artery stenosis.
    Song L; Li J; Gu Y; Yu H; Chen B; Guo L; Zhang J
    J Endovasc Ther; 2012 Apr; 19(2):231-8. PubMed ID: 22545889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies.
    Langwieser N; Buyer D; Schuster T; Haller B; Laugwitz KL; Ibrahim T
    J Endovasc Ther; 2014 Oct; 21(5):683-92. PubMed ID: 25290797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-Term Follow-Up of Drug-Eluting Stenting for In-Stent Restenosis: Bare-Metal Stents versus Drug-Eluting Stents.
    Faramarzi N; Salarifar M; Kassaian SE; Zeinali AM; Alidoosti M; Pourhoseini H; Nematipour E; Mousavi MR; Goodarzynejad H
    J Tehran Heart Cent; 2013 Jan; 8(1):14-20. PubMed ID: 23646043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis.
    Habara S; Iwabuchi M; Inoue N; Nakamura S; Asano R; Nanto S; Hayashi Y; Shiode N; Saito S; Ikari Y; Kimura T; Hosokawa J; Nakamura M; Kotani J; Kozuma K; Mitsudo K
    Am Heart J; 2013 Sep; 166(3):527-33. PubMed ID: 24016503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The sirolimus-eluting Cypher Select coronary stent for the treatment of bare-metal and drug-eluting stent restenosis: insights from the e-SELECT (Multicenter Post-Market Surveillance) registry.
    Abizaid A; Costa JR; Banning A; Bartorelli AL; Dzavik V; Ellis S; Gao R; Holmes DR; Jeong MH; Legrand V; Neumann FJ; Nyakern M; Orlick A; Spaulding C; Worthley S; Urban PM;
    JACC Cardiovasc Interv; 2012 Jan; 5(1):64-71. PubMed ID: 22230152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of clinical presentations, angiographic patterns and outcomes of in-stent restenosis between bare metal stents and drug eluting stents.
    Rathore S; Kinoshita Y; Terashima M; Katoh O; Matsuo H; Tanaka N; Kimura M; Tsuchikane E; Nasu K; Ehara M; Asakura K; Asakura Y; Suzuki T
    EuroIntervention; 2010 Feb; 5(7):841-6. PubMed ID: 20142201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of long-term results of drug-eluting stent and bare metal stent implantation in heart transplant recipients with coronary artery disease.
    Zakliczynski M; Lekston A; Osuch M; Swierad M; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2859-61. PubMed ID: 18022002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of drug-eluting stent implantation for the treatment of in-stent restenosis occurring within bare-metal stent and drug-eluting stent.
    Ge H; Zhang Q; Zhou W; He Q; Han ZH; He B
    J Zhejiang Univ Sci B; 2010 Aug; 11(8):553-60. PubMed ID: 20669344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-eluting stents versus bare-metal stents for treatment of bare-metal in-stent restenosis.
    Singh IM; Filby SJ; El Sakr F; Gorodeski EZ; Lincoff AM; Ellis SG; Shishehbor MH
    Catheter Cardiovasc Interv; 2010 Aug; 76(2):257-62. PubMed ID: 20665874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of everolimus-eluting stents in the treatment of drug-eluting stent versus bare-metal stent restenosis.
    Almalla M; Pross V; Marx N; Hoffmann R
    Coron Artery Dis; 2012 Nov; 23(7):492-6. PubMed ID: 22990414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Everolimus-Eluting Stents in Patients With Bare-Metal and Drug-Eluting In-Stent Restenosis: Results From a Patient-Level Pooled Analysis of the RIBS IV and V Trials.
    Alfonso F; Pérez-Vizcayno MJ; García Del Blanco B; García-Touchard A; López-Mínguez JR; Masotti M; Zueco J; Melgares R; Mainar V; Moreno R; Domínguez A; Sanchís J; Bethencourt A; Moreu J; Cequier A; Martí V; Otaegui I; Bastante T; Gonzalo N; Jiménez-Quevedo P; Cárdenas A; Fernández C;
    Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27412868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Clinical Results Following the Use of Drug-Eluting Balloons for a Bare-Metal Stent and Drug-Eluting Stent Instent Restenosis.
    Lee WC; Fang YN; Fang CY; Chen CJ; Yang CH; Yip HK; Hang CL; Wu CJ; Fang HY
    J Interv Cardiol; 2016 Oct; 29(5):469-479. PubMed ID: 27501848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.